Vaccine Acceptance Interventions for Coronavirus in Prisons

N/A

Recruiting

Led By Lisa B Puglisi, MD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to reduce COVID-19 cases in prisons by improving vaccine uptake through feasible interventions and studying their effectiveness.

Who is the study for?

This trial is for people detained in Pennsylvania correctional facilities, aiming to improve COVID-19 vaccine uptake. Those with severe physical or mental illness and those in special units like medical units are excluded.

What is being tested?

The study tests the effectiveness of community engagement strategies developed by the ADVANCE Steering Committee to increase COVID-19 vaccination rates among incarcerated individuals and staff.

What are the potential side effects?

Since this trial focuses on community engagement interventions rather than direct medical treatments, it does not involve typical medication side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

COVID-19 vaccine acceptance rate

Secondary study objectives

COVID-19 infections

Change in vaccination for other respiratory outbreaks

Deaths

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ADVANCE Steering Committee chosen interventionsExperimental Treatment1 Intervention

Interventions will be selected by the ADVANCE Steering Committee and will be rapidly deployed without additional effort on the part of front-line staff at four distinct levels: patient, provider, practice and prison level. Interventions will be tested one at a time in an iterative process. A participatory, assets-based framework will be used to identify acceptable and feasible strategies to improve vaccine acceptance. Each round of testing will include 1 month of preparation by the steering committee,12-week intervention period, and 2 months for analysis and rapid dissemination.

Group II: Treatment as usualActive Control1 Intervention

Participants receive standard interventions currently in use (treatment as usual).

Do I qualify?Apply below to find out